메뉴 건너뛰기




Volumn 137, Issue 2, 2012, Pages 195-204

Differential vascular expression and regulation of oncofetal tenascin-C and fibronectin variants in renal cell carcinoma (RCC): Implications for an individualized angiogenesis-related targeted drug delivery

Author keywords

Angiogenesis; Antibody based pharmacodelivery; Fibronectin; Renal cell carcinoma; Tenascin C

Indexed keywords

BEVACIZUMAB; FIBRONECTIN; MESSENGER RNA; ONCOFETAL FIBRONECTIN; ONCOFETAL TENASCIN C; TENASCIN; UNCLASSIFIED DRUG;

EID: 84857637983     PISSN: 09486143     EISSN: 1432119X     Source Type: Journal    
DOI: 10.1007/s00418-011-0886-z     Document Type: Article
Times cited : (15)

References (35)
  • 1
    • 67650763823 scopus 로고    scopus 로고
    • Fibronectins in vascular morphogenesis
    • 19219555 10.1007/s10456-009-9136-6 1:CAS:528:DC%2BD1MXnt12ntLk%3D
    • S Astrof RO Hynes 2009 Fibronectins in vascular morphogenesis Angiogenesis 12 165 175 19219555 10.1007/s10456-009-9136-6 1:CAS:528: DC%2BD1MXnt12ntLk%3D
    • (2009) Angiogenesis , vol.12 , pp. 165-175
    • Astrof, S.1    Hynes, R.O.2
  • 2
    • 70349273701 scopus 로고    scopus 로고
    • Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response
    • 10.1038/onc.2009.186 1:CAS:528:DC%2BD1MXotF2qsLs%3D
    • K Balamurugan VD Luu MR Kaufmann VS Hofmann G Boysen S Barth MR Bordoli DP Stiehl H Moch P Schraml RH Wenger G Camenisch 2009 Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response Oncog ene. 28 3274 3285 10.1038/onc.2009.186 1:CAS:528:DC%2BD1MXotF2qsLs%3D
    • (2009) Oncog Ene. , vol.28 , pp. 3274-3285
    • Balamurugan, K.1    Luu, V.D.2    Kaufmann, M.R.3    Hofmann, V.S.4    Boysen, G.5    Barth, S.6    Bordoli, M.R.7    Stiehl, D.P.8    Moch, H.9    Schraml, P.10    Wenger, R.H.11    Camenisch, G.12
  • 5
    • 77952239376 scopus 로고    scopus 로고
    • A comparative analysis of oncofetal fibronectin and tenascin-C incorporation in tumour vessels using human recombinant SIP format antibodies
    • 20237793 10.1007/s00418-010-0685-y 1:CAS:528:DC%2BC3cXjs1Olu7k%3D
    • A Berndt R Köllner P Richter M Franz A Voigt A Berndt L Borsi R Giavazzi D Neri H Kosmehl 2010 A comparative analysis of oncofetal fibronectin and tenascin-C incorporation in tumour vessels using human recombinant SIP format antibodies Histochem Cell Biol 133 467 475 20237793 10.1007/s00418-010- 0685-y 1:CAS:528:DC%2BC3cXjs1Olu7k%3D
    • (2010) Histochem Cell Biol , vol.133 , pp. 467-475
    • Berndt, A.1    Köllner, R.2    Richter, P.3    Franz, M.4    Voigt, A.5    Berndt, A.6    Borsi, L.7    Giavazzi, R.8    Neri, D.9    Kosmehl, H.10
  • 6
    • 0026457220 scopus 로고
    • Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues
    • 1385335 10.1002/ijc.2910520504 1:STN:280:DyaK3s%2Flt1ymsA%3D%3D
    • L Borsi B Carnemolla G Nicolò B Spina G Tanara L Zardi 1992 Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues Int J Cancer 52 688 692 1385335 10.1002/ijc.2910520504 1:STN:280:DyaK3s%2Flt1ymsA%3D%3D
    • (1992) Int J Cancer , vol.52 , pp. 688-692
    • Borsi, L.1    Carnemolla, B.2    Nicolò, G.3    Spina, B.4    Tanara, G.5    Zardi, L.6
  • 7
    • 33744811140 scopus 로고    scopus 로고
    • Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C
    • DOI 10.1158/1078-0432.CCR-05-2804
    • SS Brack M Silacci M Birchler D Neri 2006 Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C Clin Cancer Res 12 3200 3208 16707621 10.1158/1078-0432.CCR-05-2804 1:CAS:528:DC%2BD28Xks1Chsro%3D (Pubitemid 43837370)
    • (2006) Clinical Cancer Research , vol.12 , Issue.10 , pp. 3200-3208
    • Brack, S.S.1    Silacci, M.2    Birchler, M.3    Neri, D.4
  • 9
    • 0036493867 scopus 로고    scopus 로고
    • Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix
    • DOI 10.1182/blood.V99.5.1659
    • B Carnemolla L Borsi E Balza P Castellani R Meazza A Berndt S Ferrini H Kosmehl D Neri L Zardi 2002 Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix Blood 99 1659 1665 11861281 10.1182/blood.V99.5.1659 (Pubitemid 34533039)
    • (2002) Blood , vol.99 , Issue.5 , pp. 1659-1665
    • Carnemolla, B.1    Borsi, L.2    Balza, E.3    Castellani, P.4    Meazza, R.5    Berndt, A.6    Ferrini, S.7    Kosmehl, H.8    Neri, D.9    Zardi, L.10
  • 10
    • 72249097684 scopus 로고    scopus 로고
    • Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice
    • 19824060 10.1002/path.2626 1:CAS:528:DC%2BC3cXjsVKrtA%3D%3D
    • D Coltrini R Ronca M Belleri L Zardi S Indraccolo V Scarlato R Giavazzi M Presta 2009 Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice J Pathol 219 455 462 19824060 10.1002/path.2626 1:CAS:528:DC%2BC3cXjsVKrtA%3D%3D
    • (2009) J Pathol , vol.219 , pp. 455-462
    • Coltrini, D.1    Ronca, R.2    Belleri, M.3    Zardi, L.4    Indraccolo, S.5    Scarlato, V.6    Giavazzi, R.7    Presta, M.8
  • 11
    • 65649147889 scopus 로고    scopus 로고
    • The extracellular matrix of blood vessels
    • 19355976 10.2174/138161209787846757 1:CAS:528:DC%2BD1MXmtValtrk%3D
    • JA Eble S Niland 2009 The extracellular matrix of blood vessels Curr Pharm Des 15 1385 1400 19355976 10.2174/138161209787846757 1:CAS:528: DC%2BD1MXmtValtrk%3D
    • (2009) Curr Pharm des , vol.15 , pp. 1385-1400
    • Eble, J.A.1    Niland, S.2
  • 12
    • 77956434470 scopus 로고    scopus 로고
    • The immunocytokine F8-IL2 improves the therapeutic performance of sunitinib in a mouse model of renal cell carcinoma
    • 21030045 10.1016/j.juro.2010.07.030 1:CAS:528:DC%2BC3cXhtl2isbrI
    • K Frey C Schliemann K Schwager R Giavazzi M Johannsen D Neri 2010 The immunocytokine F8-IL2 improves the therapeutic performance of sunitinib in a mouse model of renal cell carcinoma J Urol 184 2540 2548 21030045 10.1016/j.juro.2010.07.030 1:CAS:528:DC%2BC3cXhtl2isbrI
    • (2010) J Urol , vol.184 , pp. 2540-2548
    • Frey, K.1    Schliemann, C.2    Schwager, K.3    Giavazzi, R.4    Johannsen, M.5    Neri, D.6
  • 13
    • 27744527762 scopus 로고    scopus 로고
    • Laminin-5 with transforming growth factor-β1 induces epithelial to mesenchymal transition in hepatocellular carcinoma
    • DOI 10.1053/j.gastro.2005.09.055, PII S0016508505019980
    • G Giannelli C Bergamini E Fransvea C Sgarra S Antonaci 2005 Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma Gastroenterology 129 1375 1383 16285938 10.1053/j.gastro.2005.09.055 1:CAS:528:DC%2BD2MXht12hu7fI (Pubitemid 41597379)
    • (2005) Gastroenterology , vol.129 , Issue.5 , pp. 1375-1383
    • Giannelli, G.1    Bergamini, C.2    Fransvea, E.3    Sgarra, C.4    Antonaci, S.5
  • 14
    • 0035808310 scopus 로고    scopus 로고
    • L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin
    • DOI 10.1074/jbc.M004392200
    • R Heller A Unbehaun B Schellenberg B Mayer G Werner-Felmayer ER Werner 2001 l-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin J Biol Chem 276 40 47 11022034 10.1074/jbc.M004392200 1:CAS:528:DC%2BD3MXmtV2rtQ%3D%3D (Pubitemid 32050286)
    • (2001) Journal of Biological Chemistry , vol.276 , Issue.1 , pp. 40-47
    • Heller, R.1    Unbehaun, A.2    Schellenberg, B.3    Mayer, B.4    Werner-Felmayer, G.5    Werner, E.R.6
  • 15
    • 0032693911 scopus 로고    scopus 로고
    • Synthesis and protein distribution of the unspliced large tenascin-C isoform in oral squamous cell carcinoma
    • 10629546 10.1002/(SICI)1096-9896(199912)189:4<475::AID-PATH462>3.0. CO;2-V 1:CAS:528:DC%2BD3cXltlSltg%3D%3D
    • W Hindermann A Berndt L Borsi X Luo P Hyckel D Katenkamp H Kosmehl 1999 Synthesis and protein distribution of the unspliced large tenascin-C isoform in oral squamous cell carcinoma J Pathol 189 475 480 10629546 10.1002/(SICI)1096- 9896(199912)189:4<475::AID-PATH462>3.0.CO;2-V 1:CAS:528: DC%2BD3cXltlSltg%3D%3D
    • (1999) J Pathol , vol.189 , pp. 475-480
    • Hindermann, W.1    Berndt, A.2    Borsi, L.3    Luo, X.4    Hyckel, P.5    Katenkamp, D.6    Kosmehl, H.7
  • 17
    • 58149189408 scopus 로고    scopus 로고
    • Antibody-mediated delivery of interleukin-2 to the stroma of breast cancer strongly enhances the potency of chemotherapy
    • 18927291 10.1158/1078-0432.CCR-07-5041
    • J Mårlind M Kaspar E Trachsel R Sommavilla S Hindle C Bacci L Giovannoni D Neri 2008 Antibody-mediated delivery of interleukin-2 to the stroma of breast cancer strongly enhances the potency of chemotherapy Clin Cancer Res 14 6515 6524 18927291 10.1158/1078-0432.CCR-07-5041
    • (2008) Clin Cancer Res , vol.14 , pp. 6515-6524
    • Mårlind, J.1    Kaspar, M.2    Trachsel, E.3    Sommavilla, R.4    Hindle, S.5    Bacci, C.6    Giovannoni, L.7    Neri, D.8
  • 18
    • 0031148317 scopus 로고    scopus 로고
    • RT-PCR investigation of fibronectin mRA isoforms in malignant, normal and reactive oral mucosa
    • DOI 10.1016/S0964-1955(96)00074-7, PII S0964195596000747
    • AJ Mighell J Thompson WJ Hume AF Markham PA Robinson 1997 RT-PCR investigation of fibronectin mRNA isoforms in malignant, normal and reactive oral mucosa Oral Oncol 33 155 162 9307723 10.1016/S0964-1955(96)00074-7 1:CAS:528:DyaK2sXltFCnsbg%3D (Pubitemid 27297136)
    • (1997) European Journal of Cancer Part B: Oral Oncology , vol.33 , Issue.3 , pp. 155-162
    • Mighell, A.J.1    Thompson, J.2    Hume, W.J.3    Markham, A.F.4    Robinson, P.A.5
  • 19
    • 0022492520 scopus 로고
    • Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice
    • S Naito AC von Eschenbach R Giavazzi IJ Fidler 1986 Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice Cancer Res 46 4109 4115 3731078 1:STN:280:DyaL283ntFKmtg%3D%3D (Pubitemid 16075915)
    • (1986) Cancer Research , vol.46 , Issue.8 , pp. 4109-4115
    • Naito, S.1    Von Eschenbach, A.C.2    Giavazzi, R.3    Fidler, I.J.4
  • 20
    • 20344367537 scopus 로고    scopus 로고
    • Tumour vascular targeting
    • DOI 10.1038/nrc1627
    • D Neri R Bicknell 2005 Tumour vascular targeting Nat Rev Cancer 5 436 446 15928674 10.1038/nrc1627 1:CAS:528:DC%2BD2MXks1Gmsrw%3D (Pubitemid 40791486)
    • (2005) Nature Reviews Cancer , vol.5 , Issue.6 , pp. 436-446
    • Neri, D.1    Bicknell, R.2
  • 21
    • 33749452709 scopus 로고    scopus 로고
    • Tenascin-C induced signaling in cancer
    • DOI 10.1016/j.canlet.2006.02.017, PII S0304383506001418
    • G Orend R Chiquet-Ehrismann 2006 Tenascin-C induced signaling in cancer Cancer Lett 244 143 163 16632194 10.1016/j.canlet.2006.02.017 1:CAS:528:DC%2BD28XhtVGitrjP (Pubitemid 44508708)
    • (2006) Cancer Letters , vol.244 , Issue.2 , pp. 143-163
    • Orend, G.1    Chiquet-Ehrismann, R.2
  • 22
    • 77956450051 scopus 로고    scopus 로고
    • Combination of temozolomide with immunocytokine F16-IL2 for the treatment of glioblastoma
    • 20736949 10.1038/sj.bjc.6605832 1:CAS:528:DC%2BC3cXhtFaitL7L
    • M Pedretti C Verpelli J Mårlind G Bertani C Sala D Neri L Bello 2010 Combination of temozolomide with immunocytokine F16-IL2 for the treatment of glioblastoma Br J Cancer 103 827 836 20736949 10.1038/sj.bjc.6605832 1:CAS:528:DC%2BC3cXhtFaitL7L
    • (2010) Br J Cancer , vol.103 , pp. 827-836
    • Pedretti, M.1    Verpelli, C.2    Mårlind, J.3    Bertani, G.4    Sala, C.5    Neri, D.6    Bello, L.7
  • 23
    • 77951499651 scopus 로고    scopus 로고
    • How do angiopoietins Tie in with vascular endothelial growth factors?
    • 20375888 1:CAS:528:DC%2BC3cXkvVymsbc%3D
    • P Saharinen M Bry K Alitalo 2010 How do angiopoietins Tie in with vascular endothelial growth factors? Curr Opin Hematol 17 198 205 20375888 1:CAS:528:DC%2BC3cXkvVymsbc%3D
    • (2010) Curr Opin Hematol , vol.17 , pp. 198-205
    • Saharinen, P.1    Bry, M.2    Alitalo, K.3
  • 24
    • 44349119788 scopus 로고    scopus 로고
    • Inhibition of angiogenesis by a tenascin-C peptide which is capable of activating beta1-integrins
    • DOI 10.1248/bpb.31.1003
    • Y Saito Y Shiota M Nishisaka T Owaki M Shimamura F Fukai 2008 Inhibition of angiogenesis by a tenascin-C peptide which is capable of activating beta1-integrins Biol Pharm Bull 31 1003 1007 18451535 10.1248/bpb.31.1003 1:CAS:528:DC%2BD1cXotF2mtLY%3D (Pubitemid 351731977)
    • (2008) Biological and Pharmaceutical Bulletin , vol.31 , Issue.5 , pp. 1003-1007
    • Saito, Y.1    Shiota, Y.2    Nishisaka, M.3    Owaki, T.4    Shimamura, M.5    Fukai, F.6
  • 26
    • 0032844899 scopus 로고    scopus 로고
    • The fibrinogen globe of tenascin-C promotes basic fibroblast growth factor-induced endothelial cell elongation
    • S Schenk R Chiquet-Ehrismann EJ Battegay 1999 The fibrinogen globe of tenascin-C promotes basic fibroblast growth factor-induced endothelial cell elongation Mol Biol Cell 10 2933 2943 10473637 1:CAS:528:DyaK1MXmtFeksbg%3D (Pubitemid 29441573)
    • (1999) Molecular Biology of the Cell , vol.10 , Issue.9 , pp. 2933-2943
    • Schenk, S.1    Chiquet-Ehrismann, R.2    Battegay, E.J.3
  • 27
    • 77953666915 scopus 로고    scopus 로고
    • Antibody-based vascular tumor targeting
    • 20033385 10.1007/978-3-540-78281-0-12 1:CAS:528:DC%2BC3cXovVCqsrs%3D
    • C Schliemann D Neri 2010 Antibody-based vascular tumor targeting Recent Results Cancer Res 180 201 216 20033385 10.1007/978-3-540-78281-0-12 1:CAS:528:DC%2BC3cXovVCqsrs%3D
    • (2010) Recent Results Cancer Res , vol.180 , pp. 201-216
    • Schliemann, C.1    Neri, D.2
  • 28
    • 0026233153 scopus 로고
    • Alternative splicing of fibronectin: Three variants, three functions
    • JE Schwarzbauer 1991 Alternative splicing of fibronectin: three variants, three functions Bioessays 13 527 533 1755828 10.1002/bies.950131006 1:CAS:528:DyaK38XitlGk (Pubitemid 121000502)
    • (1991) BioEssays , vol.13 , Issue.10 , pp. 527-533
    • Schwarzbauer, J.E.1
  • 29
    • 34047154015 scopus 로고    scopus 로고
    • Renal cancer cells lacking hypoxia inducible factor (HIF)-1α expression maintain vascular endothelial growth factor expression through HIF-2α
    • DOI 10.1093/carcin/bgl143
    • T Shinojima M Oya A Takayanagi R Mizuno N Shimizu M Murai 2007 Renal cancer cells lacking hypoxia inducible factor (HIF)-1alpha expression maintain vascular endothelial growth factor expression through HIF-2alpha Carcinogenesis 28 529 536 16920734 10.1093/carcin/bgl143 1:CAS:528:DC%2BD2sXjslOgu7k%3D (Pubitemid 46523348)
    • (2007) Carcinogenesis , vol.28 , Issue.3 , pp. 529-536
    • Shinojima, T.1    Oya, M.2    Takayanagi, A.3    Mizuno, R.4    Shimizu, N.5    Murai, M.6
  • 32
    • 42549099073 scopus 로고    scopus 로고
    • A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo
    • DOI 10.1002/ijc.23408
    • A Villa E Trachsel M Kaspar C Schliemann R Sommavilla JN Rybak C Rösli L Borsi D Neri 2008 A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo Int J Cancer 122 2405 2413 18271006 10.1002/ijc.23408 1:CAS:528:DC%2BD1cXltlaitbs%3D (Pubitemid 351590471)
    • (2008) International Journal of Cancer , vol.122 , Issue.11 , pp. 2405-2413
    • Villa, A.1    Trachsel, E.2    Kaspar, M.3    Schliemann, C.4    Sommavilla, R.5    Rybak, J.-N.6    Rosli, C.7    Borsi, L.8    Neri, D.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.